Collecting duct carcinoma versus renal medullary carcinoma: An appeal for nosologic and biological clarity

American Journal of Surgical Pathology

Volumn 38, Issue 7, 2014, Pages 871-874

  Amin, Mahul B ^a   Smith, Steven C ^a   Agaimy, Abbas ^k   Argani, Pedram ^b   Compérat, Eva Marie ^l   Delahunt, Brett ^m   Epstein, Jonathan I ^b   Eble, John N ^c   Grignon, David J ^c   Hartmann, Arndt ^k   Hes, Ondřej ⁿ   Hirsch, Michelle S ^d   Jimenez, Rafael E ^e   Kunju, Lakshmi P ^f   Martignoni, Guido ^o   McKenney, Jesse K ^g   Moch, Holger ^q   Montironi, Rodolfo ^p   Paner, Gladell P ^h   Rao, Priya ⁱ   Srigley, John R ^r   Tickoo, Satish K ^j   Reuter, Victor E ^j   more..

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h UNIVERSITY OF CHICAGO   (United States)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^j MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^k UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^l PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^m UNIVERSITY OF OTAGO   (New Zealand)

ⁿ CHARLES UNIVERSITY   (Czech Republic)

^o UNIVERSITY OF VERONA   (Italy)

^p United Hospitals   (Italy)

^q UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^r MCMASTER UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CANCER GRADING; CHEMISTRY; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; GENETICS; HUMAN; KIDNEY CARCINOMA; KIDNEY COLLECTING TUBULE; KIDNEY MEDULLA; KIDNEY TUMOR; NOMENCLATURE; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; REVIEW;

CARCINOMA, RENAL CELL; DIAGNOSIS, DIFFERENTIAL; HUMANS; KIDNEY MEDULLA; KIDNEY NEOPLASMS; KIDNEY TUBULES, COLLECTING; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TERMINOLOGY AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84902536586     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000222     Document Type: Review

References (26)

1. Fleming S, Lewi HJ. Collecting duct carcinoma of the kidney. Histopathology. 1986;10: 1131-1141.
2. Amin MB, Varma MB, Tickoo SK, et al. Collecting duct carcinoma of the kidney. Adv Anat Pathol. 1997;4: 85-94.
3. Srigley JR, Eble JN. Collecting duct carcinoma of kidney. Semin Diagn Pathol. 1998;15: 54-67.
4. Eble JN, World Health Organization, International Agency for Research on Cancer. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon; Oxford: IARC Press; Oxford University Press (distributor); 2004.
5. Chao D, Zisman A, Pantuck AJ, et al. Collecting duct renal cell carcinoma: clinical study of a rare tumor. J Urol. 2002;167: 71-74.
6. Peyromaure M, Thiounn N, Scotte F, et al. Collecting duct carcinoma of the kidney: a clinicopathological study of 9 cases. J Urol. 2003;170: 1138-1140.
7. Gupta R, Billis A, Shah RB, et al. Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship. Am J Surg Pathol. 2012;36: 1265-1278.
8. Albadine R, Schultz L, Illei P, et al. PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract.AmJ Surg Pathol. 2010;34: 965-969.
9. Carvalho JC, Thomas DG, McHugh JB, et al. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system. Histopathology. 2012;60: 597-608.
10. Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol. 2013;37: 1469-1489.
11. Davis CJ Jr, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol. 1995;19: 1-11.
12. Swartz MA, Karth J, Schneider DT, et al. Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology. 2002;60: 1083-1089.
13. Hakimi AA, Koi PT, Milhoua PM, et al. Renal medullary carcinoma: the Bronx experience. Urology. 2007;70: 878-882.
14. Watanabe IC, Billis A, Guimaraes MS, et al. Renal medullary carcinoma: report of seven cases from Brazil. Mod Pathol. 2007; 20: 914-920.
15. Rao P, Tannir NM, Tamboli P. Expression of OCT3/4 in renal medullary carcinoma represents a potential diagnostic pitfall. Am J Surg Pathol. 2012;36: 583-588.
16. Liu Q, Galli S, Srinivasan R, et al. Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation. Am J Surg Pathol. 2013;37: 368-374.
17. Cheng JX, Tretiakova M, Gong C, et al. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008;21: 647-652.
18. Hollmann TJ, Hornick JL. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol. 2011;35:e47-e63.
19. Calderaro J, Moroch J, Pierron G, et al. SMARCB1/INI1 inactivation in renal medullary carcinoma. Histopathology. 2012;61: 428-435.
20. Simpson L, He X, Pins M, et al. Renal medullary carcinoma and ABL gene amplification. J Urol. 2005;173: 1883-1888.
21. Debelenko LV, Raimondi SC, Daw N, et al. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum. Mod Pathol. 2011;24: 430-442.
22. Smith NE, Deyrup AT, Marino-Enriquez A, et al. VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy? Am J Surg Pathol. 2014. [Epub ahead of print]. doi: 10.1097/PAS.0000000000000179.
23. Marino-Enriquez A, Ou WB, Weldon CB, et al. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer. 2011;50: 146-153.
24. Delahunt B, Egevad L, Montironi R, et al. International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization. Am J Surg Pathol. 2013;37: 1463-1468.
25. Elwood H, Chaux A, Schultz L, et al. Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma. Urology. 2011;78:e471-e475.
26. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumours. J Pathol. 1997;183: 131-133.